The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
rac-4-(4-Chlorophenyl)-N-(3,5-dichlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-carboxamide ID: ALA4590976
PubChem CID: 155568207
Max Phase: Preclinical
Molecular Formula: C20H15Cl3N2OS
Molecular Weight: 437.78
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1cc(Cl)cc(Cl)c1)N1CCc2sccc2C1c1ccc(Cl)cc1
Standard InChI: InChI=1S/C20H15Cl3N2OS/c21-13-3-1-12(2-4-13)19-17-6-8-27-18(17)5-7-25(19)20(26)24-16-10-14(22)9-15(23)11-16/h1-4,6,8-11,19H,5,7H2,(H,24,26)
Standard InChI Key: KWWIBEXHEKAHKD-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
35.1919 -26.6258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9047 -26.2171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9047 -25.3913 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.1919 -24.9741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1923 -24.1492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9091 -23.7369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9095 -22.9119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1939 -22.4982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4763 -22.9155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4794 -23.7392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4792 -26.2171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4792 -25.3866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6895 -25.1300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2013 -25.8018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6895 -26.4736 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
36.6210 -24.9804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3350 -25.3954 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.6235 -24.1547 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.0514 -24.9846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7620 -25.4032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4778 -24.9931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4808 -24.1664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7618 -23.7516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0488 -24.1641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1916 -25.4085 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
38.7613 -22.9258 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
35.1928 -21.6724 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
12 4 1 0
11 1 1 0
1 2 1 0
2 3 1 0
3 4 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
4 5 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 11 1 0
3 16 1 0
16 17 1 0
16 18 2 0
17 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
21 25 1 0
23 26 1 0
8 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 437.78Molecular Weight (Monoisotopic): 435.9971AlogP: 6.89#Rotatable Bonds: 2Polar Surface Area: 32.34Molecular Species: NEUTRALHBA: 2HBD: 1#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.74CX Basic pKa: ┄CX LogP: 6.60CX LogD: 6.60Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.46Np Likeness Score: -1.92
References 1. Wortmann L, Lindenthal B, Muhn P, Walter A, Nubbemeyer R, Heldmann D, Sobek L, Morandi F, Schrey AK, Moosmayer D, Günther J, Kuhnke J, Koppitz M, Lücking U, Röhn U, Schäfer M, Nowak-Reppel K, Kühne R, Weinmann H, Langer G.. (2019) Discovery of BAY-298 and BAY-899: Tetrahydro-1,6-naphthyridine-Based, Potent, and Selective Antagonists of the Luteinizing Hormone Receptor Which Reduce Sex Hormone Levels in Vivo., 62 (22): [PMID:31670515 ] [10.1021/acs.jmedchem.9b01382 ]